← Leaderboards
Hildegund C. J. Ertl
Wistar Institute
$33,488,432
Attributed
$33,488,432
Total exposure
22
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $14.4M · FY2005–14$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$77,432,755 · 25
By mechanism
P01$35,501,538 · 8
U19$32,100,754 · 4
R01$3,387,915 · 4
R21$2,424,959 · 5
N01$1,724,341 · 2
U01$1,306,658 · 1
Top collaborators
No co-investigators on record.
Most similar at Wistar Institute
Same institution · by research overlap
- Paul M. Lieberman$46,496,044
- Luis J. Montaner$69,201,825
- Zhi Quan Xiang$1,180,011
Others in their field
Top investigators on “Vector Vaccine”
- Lawrence Corey · Fred Hutchinson Cancer Center$446,547,761
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$239,426,049
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$142,420,923
- Peter B. Gilbert · Fred Hutchinson Cancer Center$124,587,333
- Louis J. Picker · Oregon Health And Science University$70,366,260
- David Heimbrook · Leidos Biomedical Research, Inc.$68,561,099
Research focus
Vector VaccineImmune ResponseVectorLaboratory MouseBaseAntigensAdenovirusesInfectionT-LymphocyteVaccine DevelopmentHuman SubjectSerotypingVirusTransgenesClinical TrialsDoseMediatingImmunityAnimalsResponseAids VaccinesMacaca MulattaProgramsGenes
Grant awards (91)
Immune Responses to AAV-Mediated FIX Gene Transfer$1,647,124
P01 · FY2014 · HL · contact PI
T Cells To AAV And AAV-Encoded Transgene Products$275,118
P01 · FY2014 · HL · contact PI
Administrative Core$76,098
P01 · FY2014 · HL · contact PI
Immune Responses to AAV-Mediated FIX Gene Transfer$1,611,348
P01 · FY2013 · HL · contact PI
T Cells To AAV And AAV-Encoded Transgene Products$381,861
P01 · FY2013 · HL · contact PI
Administrative Core$74,586
P01 · FY2013 · HL · contact PI
Clinical Development of Chimp Adenovirus Vectors$2,155,092
U19 · FY2012 · AI · contact PI
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus$2,155,092
U19 · FY2012 · AI · contact PI
Immune Responses to AAV-Mediated FIX Gene Transfer$1,702,657
P01 · FY2012 · HL · contact PI
T Cells To AAV And AAV-Encoded Transgene Products$407,635
P01 · FY2012 · HL · contact PI
Administrative Core$73,289
P01 · FY2012 · HL · contact PI
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus$2,023,601
U19 · FY2011 · AI · contact PI
Immune Responses to AAV-Mediated FIX Gene Transfer$1,721,376
P01 · FY2011 · HL · contact PI
Pre-Clinical Immunogenicity Testing of Chimp Adenovirus Vectors$1,092,667
U19 · FY2011 · AI · contact PI
T Cells To AAV And AAV-Encoded Transgene Products$416,035
P01 · FY2011 · HL · contact PI
Clinical Development of Chimp Adenovirus Vectors$204,266
U19 · FY2011 · AI · contact PI
Administrative Core$118,269
U19 · FY2011 · AI · contact PI
Administrative Core$75,254
P01 · FY2011 · HL · contact PI
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus$3,041,682
U19 · FY2010 · AI · contact PI
Correlates of protection against SIV/SHIV challenge$2,749,162
P01 · FY2010 · AI · contact PI
Immune Responses to AAV-Mediated FIX Gene Transfer$1,827,678
P01 · FY2010 · HL · contact PI
Pre-Clinical Immunogenicity Testing of Chimp Adenovirus Vectors$1,479,735
U19 · FY2010 · AI · contact PI
Clinical Development of Chimp Adenovirus Vectors$753,266
U19 · FY2010 · AI · contact PI
Immune Function and Biodefense in Children, Elderly, and the Immunocrompromised$679,595
N01 · FY2010 · AI · contact PI
T Cells To AAV And AAV-Encoded Transgene Products$442,921
P01 · FY2010 · HL · contact PI
Administrative Core$139,326
U19 · FY2010 · AI · contact PI
Administrative Core$77,163
P01 · FY2010 · HL · contact PI
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus$5,092,600
U19 · FY2009 · AI · contact PI
Correlates of protection against SIV/SHIV challenge$2,832,697
P01 · FY2009 · AI · contact PI
Clinical Development of Chimp Adenovirus Vectors$2,276,038
U19 · FY2009 · AI · contact PI
Immune Responses To AAV-Mediated FIX Gene Transfer$1,774,656
P01 · FY2009 · HL · contact PI
Pre-Clinical Immunogenicity Testing of Chimp Adenovirus Vectors$1,610,354
U19 · FY2009 · AI · contact PI
GENE REPLACEMENT THERAPY AND THE IMMUNE SYSTEM$354,931
P01 · FY2009 · HL · contact PI
Administrative Core$246,655
U19 · FY2009 · AI · contact PI
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus$199,998
U19 · FY2009 · AI · contact PI
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus$2,861,413
U19 · FY2008 · AI · contact PI
Immune Responses To AAV-Mediated FIX Gene Transfer$1,618,863
P01 · FY2008 · HL · contact PI
Clinical Development of Chimp Adenovirus Vectors$1,337,138
U19 · FY2008 · AI · contact PI
Pre-Clinical Immunogenicity Testing of Chimp Adenovirus Vectors$736,884
U19 · FY2008 · AI · contact PI
GENE REPLACEMENT THERAPY AND THE IMMUNE SYSTEM$312,349
P01 · FY2008 · HL · contact PI
Administrative Core$136,577
U19 · FY2008 · AI · contact PI
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus$2,569,447
U19 · FY2007 · AI · contact PI
Immune Responses To AAV-Mediated FIX Gene Transfer$1,598,718
P01 · FY2007 · HL · contact PI
IMMUNE FUNCTION AND BIODEFENSE IN CHILDREN, ELDERLY AND IMMUNOCOMPROMISED POPULA$1,044,746
N01 · FY2007 · AI · contact PI
Clinical Development of Chimp Adenovirus Vectors$934,348
U19 · FY2007 · AI · contact PI
Pre-Clinical Immunogenicity Testing of Chimp Adenovirus Vectors$783,014
U19 · FY2007 · AI · contact PI
GENE REPLACEMENT THERAPY AND THE IMMUNE SYSTEM$306,392
P01 · FY2007 · HL · contact PI
Training Program in the Immunobiology of Vaccines$174,186
T32 · FY2007 · AI · contact PI
Administrative Core$153,292
U19 · FY2007 · AI · contact PI
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus$1,972,132
P01 · FY2006 · AI · contact PI
Immune Responses To AAV-Mediated FIX Gene Transfer$1,603,637
P01 · FY2006 · HL · contact PI
Genetic Vaccine to Rabies Virus$470,992
U01 · FY2006 · AI · contact PI
Oral Vaccine to Inhalation Rabies$452,413
R01 · FY2006 · AI · contact PI
GENE REPLACEMENT THERAPY AND THE IMMUNE SYSTEM$288,389
P01 · FY2006 · HL · contact PI
Training Program in the Immunobiology of Vaccines$171,033
T32 · FY2006 · AI · contact PI
IMMUNE FUNCTION AND BIODEFENSE IN CHILDREN. ELDERLY AND IMMUNOCOMPROMI-266050030$0
N01 · FY2006 · AI · contact PI
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus$1,960,770
P01 · FY2005 · AI
Immune Responses To AAV-Mediated FIX Gene Transfer$1,635,904
P01 · FY2005 · HL
Oral Vaccine to Inhalation Rabies$382,808
R01 · FY2005 · AI
Genetic Vaccine to Rabies Virus$364,834
U01 · FY2005 · AI
GENE REPLACEMENT THERAPY AND THE IMMUNE SYSTEM$280,376
P01 · FY2005 · HL
Training Program in the Immunobiology of Vaccines$177,488
T32 · FY2005 · AI
IMMUNE$76,792
P01 · FY2005 · HL
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus$1,903,655
P01 · FY2004 · AI
Genetic Vaccine to Rabies Virus$470,832
U01 · FY2004 · AI
DNA VACCINES-RESPONSES TO VECTORS WITH RABIES ANTIGENS$281,806
R01 · FY2004 · AI
E1-deleted adenoviral vectors for oral immunization$252,853
R21 · FY2004 · DE
Prime-boost regimens for adenoviral vaccines to HIV-1$244,548
R21 · FY2004 · AI
Oral Vaccine to Inhalation Rabies$228,001
R01 · FY2004 · AI
Training Program in the Immunobiology of Vaccines$172,125
T32 · FY2004 · AI
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus$1,836,451
P01 · FY2003 · AI
DNA VACCINES-RESPONSES TO VECTORS WITH RABIES ANTIGENS$273,598
R01 · FY2003 · AI
E1-deleted adenoviral vectors for oral immunization$248,897
R21 · FY2003 · DE
Prime-boost regimens for adenoviral vaccines to HIV-1$240,912
R21 · FY2003 · AI
HIV-1 Vaccine-Induced CD8+ Memory Cells$238,064
R21 · FY2003 · AI
Training Program in the Immunobiology of Vaccines$162,334
T32 · FY2003 · AI
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus$1,585,521
P01 · FY2002 · AI
Mucosal Vaccine to HIV-1 Gag$244,456
R21 · FY2002 · AI
HIV-1 Vaccine-Induced CD8+ Memory Cells$234,677
R21 · FY2002 · AI
DNA VACCINES-RESPONSES TO VECTORS WITH RABIES ANTIGENS$210,293
R01 · FY2002 · AI
Immune response to Adenoviral recombinants of Chimpanzee$0
P01 · FY2002 · AI
CANCER VACCINE TO P53$284,039
R01 · FY2001 · CA
DNA VACCINES-RESPONSES TO VECTORS WITH RABIES ANTIGENS$257,891
R01 · FY2001 · AI
CANCER VACCINES TO HPV-16 ASSOCIATED TUMOR$249,088
R01 · FY2001 · CA
DNA VACCINE TO HIV BASED ON CYTOKINE INDUCIBLE PROMOTER$241,627
R21 · FY2001 · AI
Mucosal Vaccine to HIV-1 Gag$240,823
R21 · FY2001 · AI
CANCER VACCINE TO P53$275,766
R01 · FY2000 · CA
DNA VACCINES-RESPONSES TO VECTORS WITH RABIES ANTIGENS$250,380
R01 · FY2000 · AI
CANCER VACCINES TO HPV-16 ASSOCIATED TUMOR$241,832
R01 · FY2000 · CA
DNA VACCINE TO HIV BASED ON CYTOKINE INDUCIBLE PROMOTER$238,102
R21 · FY2000 · AI
TRAINING PROGRAM IN THE IMMUNOBIOLOGY OF VACCINES$129,424
T32 · FY2000 · AI